About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25

Company to highlight patient-trial matching platform, real-world evidence solutions, and recent scientific contributions

Massive Bio, a global company specializing in AI-powered clinical trial matching and oncology data solutions, is participating in the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30 to June 3 at McCormick Place in Chicago, Illinois. The company is exhibiting at Booth IH04 in the Innovation Hub, where its team is presenting its technology platform and initiatives to support clinical trial enrollment and data-driven decision-making in oncology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530029983/en/

Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25

Massive Bio to Showcase AI-Driven Oncology Innovations at ASCO25

Massive Bio’s participation reflects its commitment to expanding access to clinical research through digital innovation and real-world data.

"At Massive Bio, we’ve always believed that access to clinical trials should not depend on geography, income, or system navigation," said Selin Kurnaz, Co-founder and Chief Executive Officer of Massive Bio. "ASCO25 is more than a conference. It’s where meaningful partnerships are formed and shared challenges are addressed. We’re honored to stand among those pushing the boundaries of what’s possible for cancer patients worldwide."

Selin Kurnaz will be participating in the PCC Drop-In Session at ASCO on May 30, 2025. This event brings together key stakeholders in precision oncology to discuss advancements in comprehensive genomic profiling, clinical trial matching, and patient-centered care.

"ASCO is where science, technology, and care delivery converge," said Çağatay Çulcuoğlu, Co-founder, Chief Technology Officer and Chief Operating Officer of Massive Bio. "We’re bringing not just advanced technology, but a vision for a more connected and intelligent ecosystem. One where data informs better decisions and every patient has a fair chance to engage in research."

Scientific Contributions by Dr. Arturo Loaiza-Bonilla

Massive Bio’s Co-founder and Chief Medical Officer, Dr. Arturo Loaiza-Bonilla, is delivering two presentations at ASCO25:

  • Poster Presentation

    Title: Transforming oncology clinical trial matching through multi-agent AI and an oncology-specific knowledge graph: A prospective evaluation in 3,800 patients

    Track: Care Delivery / Models of Care

    Abstract: 1554 | Poster Board: 320
  • Oral Presentation (ASCO/ESMO Joint Session)

    Title: Advancing Cancer Research and Patient-Centric Pre-Screening Hubs—Leveraging Digital Technologies

    Date and Time: June 1, 2025, 1:31 to 1:43 PM CDT

Dr. Loaiza-Bonilla is also co-author of a recent NEJM AI article titled “Harnessing Moravec’s Paradox in Health Care: A New Era of Collaborative Intelligence,” which explores the role of AI in improving research workflows and enabling patient-centric trial access.

"Technology has matured to a point where it can meet patients at the right time, with the right opportunity, no matter how complex the diagnosis," said Dr. Arturo Loaiza-Bonilla, Co-founder and Chief Medical Officer. "At ASCO25, we’re proud to share how real-world data, artificial intelligence, and clinical expertise are coming together to break longstanding barriers in oncology research."

Highlights at Booth IH04

ASCO25 attendees visiting Massive Bio’s booth can:

  • View demonstrations of the company’s AI-driven clinical trial matching platform
  • Learn more about DUO, a real-world data solution for healthcare analytics and provider engagement
  • Meet with the clinical and commercial teams to explore collaboration opportunities

Meetings can be scheduled in advance at www.massivebio.com/asco25.

About Massive Bio

Massive Bio, co-founded by Selin Kurnaz, Arturo Loaiza-Bonilla, and Çağatay Çulcuoğlu, transforms the pharmaceutical value chain with AI-driven solutions. As an AI-enabled real-world data company, it streamlines the patient journey, enhances access to advanced treatment options, and optimizes clinical trials. Massive Bio collaborates with pharmaceutical companies, research organizations, and healthcare institutions worldwide. A founding member of the CancerX public-private partnership and participant in the Cancer Moonshot White House initiative, the company has received recognition from the National Cancer Institute and operates across 17 countries with a global team of over 100 employees. For more information, visit www.massivebio.com.

"Technology has matured to a point where it can meet patients at the right time, with the right opportunity, no matter how complex the diagnosis" Dr. Arturo Loaiza-Bonilla

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.